The U.S. pharmaceutical industry is attempting to delay the timeline for Medicare's drug price negotiations following the ...

With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.

Seven lobbyists and executives who work with top pharmaceutical and biotech companies told Reuters they are pushing to delay ...

The lesson began over the weekend when the president’s son, Donald Trump Jr. — someone never tethered to the truth in his pursuit of liberal tears — reposted a social media message claiming that ...

The Phoenix congressman had to push aside independent Kyrsten Sinema without hurting his chances against Republican Kari Lake ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

What tax policies is Trump likely to support? The following is a reasoned, practical and appropriately sardonic meditation on that question.

The number of Texans seeking health care coverage under the Affordable Care Act has more than tripled since 2020.

President-Elect Donald Trump will go up against a familiar adversary as he prepares to fulfill campaign promises of a swift ...

The 2024 election was really all about what to do with the expiring 2017 Tax Cuts and Jobs Act, columnist Michael Taylor says.

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

Republican lawmakers share President-elect Donald Trump’s desire to reduce spending, but some disagree with his plan to ...